Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

541.89
+60.4212.55%
Pre-market: 553.0011.11+2.05%09:06 EDT
Volume:3.34M
Turnover:1.79B
Market Cap:23.24B
PE:19.39
High:557.37
Open:482.20
Low:475.46
Close:481.47
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:6.52
T/O Rate:8.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.63
PE(LYR):19.45

Loading ...

United Therapeutics says phase 3 ADVANCE OUTCOMES trial meets primary endpoint for ralinepag

Reuters
·
May 18

United Therapeutics Corp: Phase 3 Advance Outcomes Study Met Its Primary Endpoint

THOMSON REUTERS
·
May 18

United Therapeutics Corporation Announces Advance Outcomes Study of Ralinepag Presented at ATS 2026

THOMSON REUTERS
·
May 18

United Therapeutics wins FDA clearance for UHeart xenotransplant trial

Reuters
·
May 16

United Therapeutics Corp - Express Study to Enroll Initial Cohort of up to Two Participants

THOMSON REUTERS
·
May 16

United Therapeutics Corporation Announces FDA Clearance to Proceed With Uheart Xenotransplantation Clinical Trial

THOMSON REUTERS
·
May 16

United Therapeutics CEO Martine Rothblatt disposes of USD 6.96 million in shares

Reuters
·
May 16

United Therapeutics CFO James Edgemond sells 9,000 shares for $5,162,421.22

Reuters
·
May 16

United Therapeutics, Varda to Study Space-Based Drug Manufacturing for Pulmonary Disease Treatments

MT Newswires Live
·
May 13

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease

THOMSON REUTERS
·
May 13

United Therapeutics CEO Martine Rothblatt sells USD 2.66 million in shares

Reuters
·
May 13

United Therapeutics CFO James Edgemond sells USD 5.74 million common shares

Reuters
·
May 13

United Therapeutics CFO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 12

United Therapeutics CFO James Edgemond sells common shares worth $4.17 million

Reuters
·
May 11

United Therapeutics CEO Martine Rothblatt disposes of 8,225 shares for $4.78 million

Reuters
·
May 11

United Therapeutics to present positive data of treprostinil in IPF

TIPRANKS
·
May 11

United Therapeutics presents Phase 3 ADVANCE OUTCOMES ralinepag PAH trial data at ATS 2026

Reuters
·
May 11

Assessing United Therapeutics (UTHR) Valuation After A Strong Year Of Shareholder Returns

Simply Wall St.
·
May 10

United Therapeutics EVP, General Counsel Paul Mahon disposes 8,300 shares for $4.86 million

Reuters
·
May 08

United Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 08